Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Chapman

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Thrombosis Research|August 1, 1990
Deletion of a tripeptide sequence from the growth-factor domain of tissue-type plasminogen activator prolongs in vivo circulationM J Browne, C G Chapman, I Dodd, et al.
Digestive Diseases and Sciences|May 2, 2019
Partially Covered Versus Uncovered Self-Expandable Metal Stents: Coating Nor Diameter Affect Clinical OutcomesS P Shamah, C G Chapman, H Haider, et al.
The Journal of Physiology|March 4, 2003
Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem P domain K+ channels in central neuroprotectionP Miller, P J Kemp, A Lewis, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 1, 1993
Deletion of residues K296-G302 from the slowly-cleared tissue-type plasminogen activator t-PA del (G) leads to partial loss of plasminogen activating activityI Dodd, M J Browne, C G Chapman, et al.
Biochemical and Biophysical Research Communications|August 2, 2001
Recombinant hTASK1 is an O(2)-sensitive K(+) channelA Lewis, M E Hartness, C G Chapman, et al.
Pflugers Archiv : European Journal of Physiology|April 28, 2000
Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channelH J Meadows, C D Benham, W Cairns, et al.
Biochemical Society Transactions|May 1, 1994
Structure/function analysis of interleukin 4: interspecies comparison and site-directed mutagenesisC G Chapman, H E Clinkenbeard, K E Parker, et al.
Brain Research|February 15, 2001
The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAKH J Meadows, C G Chapman, D M Duckworth, et al.
Brain Research. Molecular Brain Research|February 13, 2001
Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and peripheryA D Medhurst, G Rennie, C G Chapman, et al.
Gene|January 1, 1985
Isolation of a human tissue-type plasminogen-activator genomic DNA clone and its expression in mouse L cellsM J Browne, A W Tyrrell, C G Chapman, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Thrombosis Research|August 1, 1990
Deletion of a tripeptide sequence from the growth-factor domain of tissue-type plasminogen activator prolongs in vivo circulationM J Browne, C G Chapman, I Dodd, et al.
Digestive Diseases and Sciences|May 2, 2019
Partially Covered Versus Uncovered Self-Expandable Metal Stents: Coating Nor Diameter Affect Clinical OutcomesS P Shamah, C G Chapman, H Haider, et al.
The Journal of Physiology|March 4, 2003
Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem P domain K+ channels in central neuroprotectionP Miller, P J Kemp, A Lewis, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 1, 1993
Deletion of residues K296-G302 from the slowly-cleared tissue-type plasminogen activator t-PA del (G) leads to partial loss of plasminogen activating activityI Dodd, M J Browne, C G Chapman, et al.
Biochemical and Biophysical Research Communications|August 2, 2001
Recombinant hTASK1 is an O(2)-sensitive K(+) channelA Lewis, M E Hartness, C G Chapman, et al.
Pflugers Archiv : European Journal of Physiology|April 28, 2000
Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channelH J Meadows, C D Benham, W Cairns, et al.
Biochemical Society Transactions|May 1, 1994
Structure/function analysis of interleukin 4: interspecies comparison and site-directed mutagenesisC G Chapman, H E Clinkenbeard, K E Parker, et al.
Brain Research|February 15, 2001
The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAKH J Meadows, C G Chapman, D M Duckworth, et al.
Brain Research. Molecular Brain Research|February 13, 2001
Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and peripheryA D Medhurst, G Rennie, C G Chapman, et al.
Gene|January 1, 1985
Isolation of a human tissue-type plasminogen-activator genomic DNA clone and its expression in mouse L cellsM J Browne, A W Tyrrell, C G Chapman, et al.
Pageof 3